NICE Technology Appraisal Board for Dupilumab

Weller, R. (Advisor)

Activity: Consultancy typesWork on advisory panel to industry or government or non-government organisation

Description

Dupilumab assessment. I was one of three UK dermatologists chosen to be expert witnesses by the British Assoc Dermatology
Period6 Mar 2018
Work forNational Institute for Clinical Excellence, United Kingdom
Degree of RecognitionNational